Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Oxidative Stress
2017 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
The discovery and development of HMG-CoA reductase inhibitors.
1992
Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3
2015 Standout
Sirtuins as regulators of metabolism and healthspan
2012 Standout
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
2016
Characterization of lipid and lipoprotein metabolism in primary human hepatocytes
2012
The Role of Short-Chain Fatty Acids in Health and Disease
2014 Standout
Influence of Metabolism on Epigenetics and Disease
2013 StandoutNobel
Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
1990 Standout
Niacin and cholesterol: role in cardiovascular disease (review)
2003
Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: An in vitro model of the niacin flush
2006
Does nicotinic acid (niacin) lower blood pressure?
2008
Mechanism of Action of Niacin
2008
Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis
2014 Standout
Ageing as a risk factor for neurodegenerative disease
2019 Standout
NAD+ as a Signaling Molecule Modulating Metabolism
2011
NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus
2015
GPR109A (PUMA-G/HM74A) mediates nicotinic acid–induced flushing
2005
Nicotinic acid: an old drug with a promising future
2007
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
2009 Standout
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Drug Treatment of Lipid Disorders
1999
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
1992 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Diabetes and Atherosclerosis
2002 Standout
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
2010 Standout
Niacin in cardiovascular prevention: mechanisms, efficacy, and safety
2007
Poly(ADP-ribose): novel functions for an old molecule
2006 Standout
Teaching old receptors new tricks: biasing seven-transmembrane receptors
2010 StandoutNobel
β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
2009 StandoutNobel
New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre?
2010 Standout
Niacin therapy in atherosclerosis
2004
ESPEN Guidelines on Enteral Nutrition: Gastroenterology
2006
Effect of Niacin on Lipid and Lipoprotein Levels and Glycemic Control in Patients With Diabetes and Peripheral Arterial Disease
2000
Targeting Sirtuin 1 to Improve Metabolism: All You Need Is NAD+?
2011
Discoveries of Nicotinamide Riboside as a Nutrient and Conserved NRK Genes Establish a Preiss-Handler Independent Route to NAD+ in Fungi and Humans
2004
Safety Considerations with Niacin Therapy
2006
Niacin inhibits skin dendritic cell mobilization in a GPR109A independent manner but has no impact on monocyte trafficking in atherosclerosis
2011
Nicotinic acid: the broad‐spectrum lipid drug. A 50th anniversary review
2005
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
2013 Standout
Nicotinic Acid: A Review of Its Clinical Use in the Treatment of Lipid Disorders
1988
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Extended-release niacin for modifying the lipoprotein profile
2004
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
1975 Standout
Factors affecting lipoprotein metabolism.
1965
Influence of the Nutritional State on the Inhibition of Lipolysis in Adipose Tissue by Prostaglandin El and Nicotinic Acid Prostaglandin and related factors 46
1965 StandoutNobel
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Apolipoprotein E polymorphism and atherosclerosis.
1988 Standout
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Total Synthesis of α-Pyrone Meroterpenoids, Novel Bioactive Microbial Metabolites
2005 StandoutNobel
Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease
1971 Standout
Niacin therapy in atherosclerosis
2005
Microsurgical Inguinal Varicocelectomy With Delivery of the Testis: An Artery and Lymphatic Sparing Technique
1992 Standout
III Diretrizes Brasileiras Sobre Dislipidemias e Diretriz de Prevenção da Aterosclerose do Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia
2001 Standout
Human serum leads to differentiation of human hepatoma cells, restoration of very-low-density lipoprotein secretion, and a 1000-fold increase in HCV Japanese fulminant hepatitis type 1 titers
2013 StandoutNobel
Mammalian Sirtuins: Biological Insights and Disease Relevance
2010 Standout
Nicotinic Acid: Pharmacological Effects and Mechanisms of Action
2007
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Spermidine in health and disease
2018 StandoutScience
Type II hyperlipoproteinaemia
1973
The LDL Pathway in Human Fibroblasts: A Receptor-Mediated Mechanism for the Regulation of Cholesterol Metabolism
1976 StandoutNobel
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
1967 Standout
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Nowy rok, stare problemy, ale i nowe możliwości
2014 Standout
Microwave-Assisted Synthesis in Water as Solvent
2007 Standout
1-Alkyl-benzotriazole-5-carboxylic Acids Are Highly Selective Agonists of the Human Orphan G-Protein-Coupled Receptor GPR109b
2006
A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn’s Disease Flares
2019 Standout
Niacin Decreases Removal of High-Density Lipoprotein Apolipoprotein A-I But Not Cholesterol Ester by Hep G2 Cells
1997
Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: Clues to mechanism of action of niacin
1985
Niacin, but Not Gemfibrozil, Selectively Increases LP-AI, a Cardioprotective Subfraction of HDL, in Patients With Low HDL Cholesterol
2001
The plasma lecithin:cholesterol acyltransferase reaction
1968 Standout
Dietary and Drug Treatment of Primary Hyperlipoproteinemia
1972
Type III Hyperlipoproteinemia: Diagnosis, Molecular Defects, Pathology, and Treatment
1983
Lipid Mobilization in Essential Fatty Acid Deficient Rats A preliminary note Prostaglandin and related factors 39
1965 StandoutNobel
Studies on the Role of Adenosine 3',5'-Monophosphate in the Hepatic Actions of Glucagon and Catecholamines
1971 StandoutNobel
Studies on the Effect of Nicotinic Acid on Catecholamine Stimulated Lipolysis in Adipose Tissue in Vitro
1963
Lipid-Lowering Drugs
1987
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Hypercholesteremia and nicotinic acid
1961
Hyperlipidemia in Coronary Heart Disease I. LIPID LEVELS IN 500 SURVIVORS OF MYOCARDIAL INFARCTION
1973 StandoutNobel
EFFECT OF NICOTINIC ACID ON SERUM-LIPIDS
1959
Inhibitory Action of Prostaglandin E1 on the Mobilization of Free Fatty Acids and Glycerol from Human Adipose Tissue in Vitro Prostaglandin and related factors
1965 StandoutNobel
Current Metabolic-Genetic Interrelationship in Human Atherosclerosis
1968
Nicotinic Acid Maculopathy
1973
The Secret Life of NAD+: An Old Metabolite Controlling New Metabolic Signaling Pathways
2010
Exploring the therapeutic space around NAD+
2012
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
1988 Standout
Works of J. Stephen being referenced
Influence of nicotinic acid on serum cholesterol in man
1955
Octreotide as an Adjunct to Home Parenteral Nutrition in the Management of Permanent End‐Jejunostomy Syndrome
1994